Page 4 - Viral Vector News Today

Dublin, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The

Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis:...

Forecasts by Type (Preventive Vaccines, Therapeutic Vaccines), by Technology (Dendritic Cells, Recombinant, Antigen/Adjuvant, Viral Vector and DNA,...

Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "RNAi Drug Delivery: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's...

SEATTLE, August 23, 2023--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a capacity update with the addition of three new Grade B cell therapy suites to its Longmont, CO facility.

Researchers evaluated distinct immune responses to mRNA and vector-based COVID-19 vaccines and natural SARS-CoV-2 infections.

/PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce a Request for Information (RFI)...

In a recent study, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine.

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

/PRNewswire/ -- The "Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.coms offering....